Geode Capital Management LLC acquired a new position in shares of Orgenesis Inc (OTCMKTS:ORGS) during the 4th quarter, HoldingsChannel reports. The institutional investor acquired 45,425 shares of the company’s stock, valued at approximately $212,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in ORGS. Vanguard Group Inc. grew its stake in shares of Orgenesis by 63.2% in the 3rd quarter. Vanguard Group Inc. now owns 236,324 shares of the company’s stock worth $1,309,000 after acquiring an additional 91,507 shares in the last quarter. Vanguard Group Inc grew its stake in shares of Orgenesis by 63.2% in the 3rd quarter. Vanguard Group Inc now owns 236,324 shares of the company’s stock worth $1,309,000 after acquiring an additional 91,507 shares in the last quarter. Cheyne Capital Management UK LLP bought a new stake in shares of Orgenesis in the 4th quarter worth $183,000. BlackRock Inc. grew its stake in shares of Orgenesis by 44.6% in the 4th quarter. BlackRock Inc. now owns 28,886 shares of the company’s stock worth $135,000 after acquiring an additional 8,909 shares in the last quarter. Finally, Northern Trust Corp bought a new stake in shares of Orgenesis in the 4th quarter worth $70,000.

OTCMKTS ORGS opened at $4.50 on Thursday. Orgenesis Inc has a 1 year low of $3.87 and a 1 year high of $9.50.

Orgenesis (OTCMKTS:ORGS) last posted its earnings results on Wednesday, February 13th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.21) by ($0.18). The firm had revenue of $5.80 million for the quarter, compared to analysts’ expectations of $7.78 million.

COPYRIGHT VIOLATION WARNING: “Geode Capital Management LLC Takes Position in Orgenesis Inc (ORGS)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was copied illegally and reposted in violation of US and international copyright laws. The correct version of this report can be accessed at https://www.thecerbatgem.com/2019/05/16/geode-capital-management-llc-takes-position-in-orgenesis-inc-orgs.html.

About Orgenesis

Orgenesis Inc is a regenerative therapy company. The Company operates through two segments: Contract Development and Manufacturing Organization (CDMO) and Cellular Therapy Business (CTB). The CDMO activity is operated by the Company’s subsidiary, MaSTherCell SA, which specializes in cell therapy development for advanced medicinal products.

Recommended Story: Moving Average (MA)

Want to see what other hedge funds are holding ORGS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orgenesis Inc (OTCMKTS:ORGS).

Institutional Ownership by Quarter for Orgenesis (OTCMKTS:ORGS)

Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.